Literature DB >> 23305123

Clinical features of influenza disease in admitted children during the first postpandemic season and risk factors for hospitalization: a multicentre Spanish experience.

C Launes1, J J García-García, A Martínez-Planas, F Moraga, N Soldevila, I Astigarraga, J Arístegui, J Korta, J M Quintana, N Torner, A Domínguez.   

Abstract

The main objectives of this study were to describe the characteristics of children with influenza infection during the postpandemic outbreak, and to compare sociodemographic and clinical data between patients who required hospitalization and those managed on an outpatient basis with a matched case-control study design. This is a multicentre paediatric study in Spain that included patients aged 6 month to 18 years in whom influenza infection was confirmed by real-time reverse transcription-polymerase chain reaction between December 2010 and March 2011. Among the 143 admitted patients, the main reason for admission was respiratory failure (123/143). In 55 there was some previously known disease. The median age was lower in patients without comorbidity (1.8 years: interquartile range 1.0-3.0 versus 5.3 years: interquartile range 1.3-10.7); p <0.01). The lag time from onset of symptoms to starting antiviral treatment was correlated with the length of hospital stay (Rho Spearman = + 0.32; p 0.01). Twenty patients required admission to the paediatric intensive care units, all due to respiratory failure. Children with chest X-ray opacities in more than one quadrant more frequently required admission to intensive care. Having a neurological disease conferred the highest risk of requiring hospitalization (OR 17.18) in a multivariate analysis. This study concludes that influenza in the paediatric population requiring hospitalization during the postpandemic season affected mainly children with neurological or pulmonary comorbidities and children of parents with a lower educational level. Most of the influenza infections caused respiratory symptoms, although neurological manifestations were also observed. Early initiation of oseltamivir was associated with a shorter length of hospital stay.
© 2012 The Authors Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Year:  2013        PMID: 23305123     DOI: 10.1111/1469-0691.12106

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  7 in total

Review 1.  Control selection methods in recent case-control studies conducted as part of infectious disease outbreaks.

Authors:  Alison Waldram; Caoimhe McKerr; Maya Gobin; Goutam Adak; James M Stuart; Paul Cleary
Journal:  Eur J Epidemiol       Date:  2015-03-12       Impact factor: 8.082

2.  Influenza vaccination coverage and effectiveness in young children in Thailand, 2011-2013.

Authors:  Wanitchaya Kittikraisak; Piyarat Suntarattiwong; Jens Levy; Stefan Fernandez; Fatimah S Dawood; Sonja J Olsen; Tawee Chotpitayasunondh
Journal:  Influenza Other Respir Viruses       Date:  2015-01-05       Impact factor: 4.380

3.  Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection.

Authors:  Sudhir Venkatesan; Puja R Myles; Kirsty J Bolton; Stella G Muthuri; Tarig Al Khuwaitir; Ashish P Anovadiya; Eduardo Azziz-Baumgartner; Tahar Bajjou; Matteo Bassetti; Bojana Beovic; Barbara Bertisch; Isabelle Bonmarin; Robert Booy; Victor H Borja-Aburto; Heinz Burgmann; Bin Cao; Jordi Carratala; Tserendorj Chinbayar; Catia Cilloniz; Justin T Denholm; Samuel R Dominguez; Pericles A D Duarte; Gal Dubnov-Raz; Sergio Fanella; Zhancheng Gao; Patrick Gérardin; Maddalena Giannella; Sophie Gubbels; Jethro Herberg; Anjarath Lorena Higuera Iglesias; Peter H Hoeger; Xiao Yun Hu; Quazi T Islam; Mirela F Jiménez; Gerben Keijzers; Hossein Khalili; Gabriela Kusznierz; Ilija Kuzman; Eduard Langenegger; Kamran B Lankarani; Yee-Sin Leo; Romina P Libster; Rita Linko; Faris Madanat; Efstratios Maltezos; Abdullah Mamun; Toshie Manabe; Gokhan Metan; Auksė Mickiene; Dragan Mikić; Kristin G I Mohn; Maria E Oliva; Mehpare Ozkan; Dhruv Parekh; Mical Paul; Barbara A Rath; Samir Refaey; Alejandro H Rodríguez; Bunyamin Sertogullarindan; Joanna Skręt-Magierło; Ayper Somer; Ewa Talarek; Julian W Tang; Kelvin To; Dat Tran; Timothy M Uyeki; Wendy Vaudry; Tjasa Vidmar; Paul Zarogoulidis; Jonathan S Nguyen-Van-Tam
Journal:  J Infect Dis       Date:  2020-01-14       Impact factor: 5.226

4.  Economic issues of Severe Acute Respiratory Infections for influenza in Mexican children attended in a tertiary public hospital.

Authors:  Alfonso Reyes-Lopez; Sarbelio Moreno-Espinosa; Yosef Olaf Hernandez-Olivares; Jimenez-Juarez Rodolfo Norberto
Journal:  PLoS One       Date:  2022-09-09       Impact factor: 3.752

5.  Continued high incidence of children with severe influenza A(H1N1)pdm09 admitted to paediatric intensive care units in Germany during the first three post-pandemic influenza seasons, 2010/11-2012/13.

Authors:  Andrea Streng; Christiane Prifert; Benedikt Weissbrich; Johannes G Liese
Journal:  BMC Infect Dis       Date:  2015-12-18       Impact factor: 3.090

6.  Comparison of incidence and cost of influenza between healthy and high-risk children <60 months old in Thailand, 2011-2015.

Authors:  Wanitchaya Kittikraisak; Piyarat Suntarattiwong; Wiboon Kanjanapattanakul; Darunee Ditsungnoen; Chonticha Klungthong; Kim A Lindblade; Stefan Fernandez; Fatimah S Dawood; Tawee Chotpitayasunondh; Sonja J Olsen
Journal:  PLoS One       Date:  2018-05-17       Impact factor: 3.240

7.  Influenza epidemiology and risk factors for severe acute respiratory infection in Morocco during the 2016/2017 and 2017/2018 seasons.

Authors:  Hind Ezzine; Imad Cherkaoui; Ahmed Rguig; Hicham Oumzil; Mouad Mrabet; Abderrahman Bimouhen; Fatima El Falaki; Zakia Regragui; Zineb Tarhda; Mohammed Youbi; Mariam Naciri
Journal:  Pan Afr Med J       Date:  2020-07-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.